Weighless MD - Brookfield

Weighless MD - Brookfield operates as a physician-supervised weight management clinic in Brookfield, Wisconsin, where medical director oversight guides the integration of peptide-based therapies with metabolic health protocols. Since opening in 2015, the clinic has focused exclusively on weight reduction and metabolic optimization, building a patient base that accesses care through both in-person appointments at the Brookfield location and telehealth consultations available to Wisconsin residents. The clinic's approach centers on pharmacological interventions combined with structured dietary planning, distinguishing it from wellness centers that emphasize lifestyle modification alone.

The peptide therapy program at Weighless MD - Brookfield includes three GLP-1 receptor agonists and dual-action agents: semaglutide, tirzepatide, and retatrutide. Semaglutide is prescribed for patients requiring appetite regulation and glycemic control, typically initiated at lower doses and titrated based on tolerance and weight loss velocity. Tirzepatide, which activates both GIP and GLP-1 receptors, is offered to patients who may benefit from enhanced insulin sensitivity alongside appetite suppression, particularly those with prediabetic markers or insulin resistance patterns. Retatrutide represents the clinic's most recent addition—a triple-agonist peptide targeting GLP-1, GIP, and glucagon receptors—reserved for patients with higher BMI thresholds or those who have plateaued on dual-agonist therapy. Each peptide protocol includes baseline metabolic panel assessment, body composition analysis, and monitoring schedules that track both weight metrics and cardiometabolic markers throughout treatment.

The medical team in Brookfield includes physicians trained in obesity medicine who conduct initial consultations to determine peptide candidacy based on medical history, current medications, and contraindication screening. Patients undergo evaluation for thyroid function, liver enzymes, and renal markers before peptide initiation, with particular attention to excluding medullary thyroid carcinoma history or multiple endocrine neoplasia syndrome type 2. The clinic's dietary component involves registered dietitian collaboration, where patients receive macronutrient targets calibrated to their peptide regimen—higher protein ratios are emphasized during active weight loss phases to preserve lean mass, while carbohydrate timing is adjusted based on individual glycemic response patterns documented through continuous glucose monitoring when clinically indicated.

Patients beginning treatment at Weighless MD - Brookfield follow a structured onboarding sequence: an initial medical consultation establishes baseline health status and weight loss goals, followed by laboratory work completed at affiliated Wisconsin facilities or through at-home collection kits for telehealth patients. Once peptide therapy begins, patients attend or log into follow-up appointments at two-week intervals during dose escalation phases, then monthly once maintenance dosing is achieved. The clinic provides injection technique training for subcutaneous administration, supplies sharps containers, and maintains a clinical support line for questions about injection site reactions, gastrointestinal side effects, or dose timing adjustments. Weight and body composition measurements are recorded at each visit to calculate loss velocity and adjust caloric targets accordingly.

For Wisconsin residents unable to travel to Brookfield, the clinic's telehealth platform replicates the in-person care model through video consultations, electronic prescription routing to patients' preferred Wisconsin pharmacies, and digital tracking tools that patients use to log weight, food intake, and side effect profiles. Prescriptions are sent to compounding pharmacies or retail locations depending on peptide availability and insurance coverage parameters. The hybrid model allows patients to alternate between virtual check-ins and periodic in-person visits for body composition scanning or more detailed metabolic testing, providing flexibility for those in Milwaukee, Madison, or other Wisconsin cities. Weighless MD - Brookfield maintains its focus on medically supervised pharmacotherapy rather than surgical referrals, positioning itself for patients seeking pharmaceutical intervention before considering bariatric procedures or as an alternative to invasive weight loss methods.